This content is machine translated Type 2 diabetes Remission is not a “mission impossible” Recent study findings show that diabetes remission can be achieved in overweight patients with early-stage type 2 diabetes through intensive nutritional therapy with sustained weight loss, and that some patients…
View Post 7 min This content is machine translated Biologics for AD Interleukin-13 as a target – new long-term data available Now that the range of systemic therapeutics for atopic dermatitis has been expanded and the two monoclonal antibodies dupilumab and tralokinumab as well as three Janus kinase inhibitors have been…
View Post 4 min This content is machine translated Atopic dermatitis Long-term efficacy of baricitinib proven In adult patients with moderate to severe atopic dermatitis, long-term therapy with the JAK inhibitor baricitinib maintained improvements achieved after 16 weeks for 68 weeks, new data show. A pooled…
View Post 3 min This content is machine translated Migraine prophylaxis Positive long-term data on fremanezumab The CGRP inhibitor proved to be an effective and safe medication in patients with chronic and episodic migraine when used over a 12-month period. Data from the extension study were…
View Post 5 min This content is machine translated ICML 2017 in Lugano Long-term data are positive At the ICML Congress, the audience gained insight into long-term data from two phase III trials in mantle cell lymphoma and chronic lymphocytic leukemia. The new results confirm the statements…
